1 / 55

QNLPD!

Nutrizione e salute: cosa c’è di nuovo nel piatto? Andrea Poli, NFI – Nutrition Foundation of Italy. QNLPD!. QNLPD! Attenzione: Questo N on L o P ossiamo D ire!. Healthy diet characteristics according to the 2016 ESC guidelines for CV prevention.

gamache
Download Presentation

QNLPD!

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nutrizione e salute: cosa c’è di nuovo nel piatto?Andrea Poli, NFI – Nutrition Foundation of Italy

  2. QNLPD!

  3. QNLPD! Attenzione: Questo Non Lo Possiamo Dire!

  4. Healthydietcharacteristicsaccording to the 2016 ESC guidelines for CV prevention Piepoli MF et al, EurHeartJ, 2016

  5. QNLPD! Saturated fats de Souza RJ et al, Brit Med J 2015

  6. Virtanen JK et al, ArteriosclThrombVascBiol 2014

  7. Total fat and different types of fat intake in spanish high risk patients of the PREDIMED cohort: effects on all-cause mortality QNLPD! Guasch-Ferré M et al, Am J Clin Nutr 2015

  8. Total fat and different types of fat intake in spanish high risk patients of the PREDIMED cohort: effects on all-cause mortality QNLPD! Guasch-Ferré M et al, Am J Clin Nutr 2015

  9. A changingview on SFAs and dairy: from enemy to friend Astrup A, Am J Clin Nutr 2014

  10. Dairy, total CVD and CHD: a metanalysis Alexander DD et al, Brit J Nutr 2016

  11. Dairy and stroke: a metanalysis Alexander DD et al, Brit J Nutr 2016

  12. Dairyintake and body weightchange in a US non-overweightwomencohort Q1 for dairyintake Q5 for dairyintake RautiainenS et al, AmJClinNutr 2016

  13. Latte e tumori: le evidenze della letteratura

  14. CHD Deathsattributable to low PUFA n-6 high SFA or high TFA in variouscountries WangQ et al, JAmHeartAssoc 2016

  15. Polyphenol intake and all-cause mortality risk: a re-analysis of the PREDIMED trial -37% Tresserra-Rimbau A et al, BMC Medicine 2014

  16. Epicatechinintake and CV risk in the Zutphenelderlycohort (25 years follow-up) Sources: tea 51%, apples 25%, cocoa 7% Dower JI et al, AmJClinNutr 2016

  17. Whole-grainintake and total, cardiovascular, and cancermortality: a systematicreview and meta-analysis of prospectivestudies Chen GC et al, AmJClinNutr 2016

  18. Whole-grainintake and total, cardiovascular, and cancermortality: a systematicreview and meta-analysis of prospectivestudies Chen GC et al, AmJClinNutr 2016

  19. Cause specific mortality, according to frequency of nut consumption Bao Y et al, N Engl J Med 2013

  20. Coffee Consumption and Mortality From All Causes, Cardiovascular Disease, and Cancer: A Dose-Response Meta-Analysis Cardiovascular mortality Crippa A et al, Am J Epidemiol 2014

  21. Coffee Consumption and Mortality From All Causes, Cardiovascular Disease, and Cancer: A Dose-Response Meta-Analysis All-cause mortality -13% Crippa A et al, Am J Epidemiol 2014

  22. Chocolate intake and myocardial infarction risk: a meta-analysis of prospective studies Larsson S et al, Heart 2016

  23. Chocolate intake and myocardial infarction risk: a meta-analysis of prospective studies Larsson S et al, Heart 2016

  24. Chocolate flavanols consumption and cognition: the Cocoa, Cognition and Aging (CoCoA) Study Mastroiacovo D et al, Am J Clin Nutr 2014

  25. Coffee consumption and incident cognitive decline: a dose-response meta-analysis Wu L et al, ClinicalNutrition 2016

  26. I molteplici effetti dei polifenoli • Effetto antiossidante (?) • Effetto antiinfiammatorio • Effetti sulla trascrizione genica • Inibizione dell’attività delle amilasi • Effetti sul microbiota (con formazione di metaboliti secondari) • Effetto sulla conversione degli omega-3 a più corta catena (ALA ed EPA) in DHA

  27. Plasma fatty acids in vegans and omnivorous Sarter B et al, Clin Nutr 2014

  28. Il minimo dell’end-point combinato mortalità/eventi CV maggiori si osserva in associazione con apporti di 5 g/die di Sodio , pari a 12,5 g di NaCl/die QNLPD! Mente A et al, Lancet, 2016

  29. Sodiumexcretion, CV events and overallmortality in subjects with and withouthypertension Mente A et al, Lancet, 2016

  30. Sodiumexcretion, CV events and overallmortality in subjects with and withouthypertension Mente A et al, Lancet, 2016

  31. Cosa ne dicono gli epidemiologi del PURE Study • Mostreviewssaysaltisdangerous, mostrecentexperimentalpapersfind no correlation or “J” shapedcorrelations • Several short-termstudiesalsodemonstrateactivationof the renin-aldosterone-angiotensinsystemwith lowsodiumintake, whichprovides a biologicalrationale for the higherrates of cardiovasculareventsreported in severalprospectivecohortstudies • Reducingsodiumintake in thoseconsuming high sodiumintake (>5 g/day), to moderate intakelevels (3–5 g/day) isnotcontroversial, asthereisgeneral consensusbased on the consistency of bloodpressure and cardiovascular data. • The controversyresides in whethersodiumintakeshould be furtherrestricted to verylowlevels (< 2.4 g/day), whichhasyet to be sustainablyachieved in anypopulation, whichis a rangewhere the effects on bloodpressure are modest and there are additionalconcernsaboutsafety. O’Donnell M et al, InternJEpidemiol 2016

  32. SBP and overall mortality in 1,000,000 Korean Adults Yi SW et al, Circulation 2016

  33. Sensibilità al sale in vari gruppi Farquhar WB et al, J Am Coll Cardiol 2015

  34. Chokshi DA et al, JAMA 2015

  35. Alcool e rischio di diabete di tipo II: una metanalisi(700k soggetti, da 26 studi, 30kcasi di diabete) Li XH et al, AmJClinNutr 2016

  36. Mozaffarian D, Circulation, 2016

  37. Markers di felicità nel “Million Women Study” Liu B et al., Lancet 2015

  38. Markers di felicità nel “Million Women Study” QNLPD! Liu B et al., Lancet 2015

  39. BMI e mortalità per tutte le cause: un bersaglio mobile? QNLPD ASSOLUTAMENTE AfzalS et al, JAMA 2016

  40. Distribuzione del consumo di zuccheri totali nello studio LIZ Marangoni et al., Eur J Nutr 2016

  41. Caratteristiche dei soggetti con differente consumo di zuccheri nello studio LIZ QNLPD! Marangoni F et al., Eur J Nutr 2016

  42. Sugar intake and CVD mortality in US Yang Q et al, JAMA InternMed 2014

  43. Sugar intake and CVD mortality in US Italy: 7/8% Yang Q et al, JAMA InternMed 2014

  44. Healthyeatingand mortality in a cohort of CHDpatientswhitstate-of-the-art drug treatment The DutchHealthyNutrient and Food Score (DHNaFS) included 11 nutrient-dense foodgroups: vegetables, fruit, wholegrains, protein-richplantfoods (mostlylegumes), potatoes, leanmeat, fish, eggs, low-fatmilk and yogurt, oils and soft margarines, and noncaloricdrinks. The DutchUndesirableNutrient and Food Score (DUNaFS) included 13 foodgroups high in solidfats, sodium, and/or added sugar: processedfruit, high-fatmeat, processedmeat, full-fatmilk, cheese; refinedgrains, butter and hard margarines, soups, spreads, ready-to-eatmeals, savorysnacks, sweetsnacks, and sugar-sweetenedbeverages. 4,307 CHD pts from the Alpha-Omega Trial, 60-80 yrs at baseline, 10 yrs follow-up Sijstma FPC et al, Am J Clin Nutr, 2015

  45. Healthyeatingand mortality in a cohort of CHDpatientswhitstate-of-the-art drug treatment All cause mortality Cardiovascular mortality 4,307 CHD pts from the Alpha-Omega Trial, 60-80 yrs at baseline, 10 yrs follow-up Sijstma FPC et al, Am J Clin Nutr, 2015

  46. Healthyeatingand mortality in a cohort of CHDpatientswhitstate-of-the-art drug treatment All cause mortality Cardiovascular mortality 4,307 CHD pts from the Alpha-Omega Trial, 60-80 yrs at baseline, 10 yrs follow-up Sijstma FPC et al, Am J Clin Nutr, 2015

More Related